Myocardial infarction (MI) affects more than 8 million people in the United States alone. Due to theinsufficient regeneration capacity of the native myocardium, one widely studied approach is cardiactissue engineering, in which cells are delivered with or without biomaterials and/or regulatory factors tofully regenerate the cardiac functions. Specifically, in vitro cardiac tissue engineering focuses on usingbiomaterials as a reservoir for cells to attach, as well as a carrier of various regulatory factors such asgrowth factors and peptides, providing high cell retention and a proper microenvironment for cells tomigrate, grow and differentiate within the scaffolds before implantation. Many studies have shown thatthe full establishment of a f...
Myocardial tissue engineering involves the design of biomaterial scaffolds, aiming at regenerating n...
The irreversible loss of functional cardiomyocytes (CMs) after myocardial infarction (MI) represents...
Introduction: One of the main problems in the rapid translation of preclinical cell\u2010based thera...
AbstractMyocardial infarction (MI) affects more than 8 million people in the United States alone. Du...
For nearly a decade, researchers have investigated the possibility of cell transplantation for cardi...
Cardiac tissue is composed of muscle and non-muscle cells, surrounded by extracellular matrix (ECM) ...
Cardiac tissue is composed of muscle and non-muscle cells, surrounded by extracellular matrix (ECM) ...
An increasing number of studies in cardiac cell therapy have provided encouraging results for cardia...
An increasing number of studies in cardiac cell therapy have provided encouraging results for cardia...
An increasing number of studies in cardiac cell therapy have provided encouraging results for cardia...
Cardiac tissue is composed of muscle and non-muscle cells, surrounded by extracellular matrix (ECM) ...
Cardiac tissue is composed of muscle and non-muscle cells, surrounded by extracellular matrix (ECM) ...
Cardiac tissue is composed of muscle and non-muscle cells, surrounded by extracellular matrix (ECM) ...
Cardiac tissue is composed of muscle and non-muscle cells, surrounded by extracellular matrix (ECM) ...
The irreversible loss of functional cardiomyocytes (CMs) after myocardial infarction (MI) represents...
Myocardial tissue engineering involves the design of biomaterial scaffolds, aiming at regenerating n...
The irreversible loss of functional cardiomyocytes (CMs) after myocardial infarction (MI) represents...
Introduction: One of the main problems in the rapid translation of preclinical cell\u2010based thera...
AbstractMyocardial infarction (MI) affects more than 8 million people in the United States alone. Du...
For nearly a decade, researchers have investigated the possibility of cell transplantation for cardi...
Cardiac tissue is composed of muscle and non-muscle cells, surrounded by extracellular matrix (ECM) ...
Cardiac tissue is composed of muscle and non-muscle cells, surrounded by extracellular matrix (ECM) ...
An increasing number of studies in cardiac cell therapy have provided encouraging results for cardia...
An increasing number of studies in cardiac cell therapy have provided encouraging results for cardia...
An increasing number of studies in cardiac cell therapy have provided encouraging results for cardia...
Cardiac tissue is composed of muscle and non-muscle cells, surrounded by extracellular matrix (ECM) ...
Cardiac tissue is composed of muscle and non-muscle cells, surrounded by extracellular matrix (ECM) ...
Cardiac tissue is composed of muscle and non-muscle cells, surrounded by extracellular matrix (ECM) ...
Cardiac tissue is composed of muscle and non-muscle cells, surrounded by extracellular matrix (ECM) ...
The irreversible loss of functional cardiomyocytes (CMs) after myocardial infarction (MI) represents...
Myocardial tissue engineering involves the design of biomaterial scaffolds, aiming at regenerating n...
The irreversible loss of functional cardiomyocytes (CMs) after myocardial infarction (MI) represents...
Introduction: One of the main problems in the rapid translation of preclinical cell\u2010based thera...